N@N

EC, NHI, ATO, TGI, BIIB, NST Expected to Trade Up Short Term

September 15, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top equities trading strategies and these stocks are the most likely to trade Up in the coming weeks. ECOPETROL SA-SPONSORED ADR (NYSE:EC), NATL HEALTH INVESTORS INC (NYSE:NHI), ATMOS ENERGY CORP (NYSE:ATO), TRIUMPH GROUP, INC. (NYSE:TGI), BIOGEN IDEC INC. (NASDAQ:BIIB), NSTAR (NYSE:NST) are all expected to go Up as Bullish signals have been generated by top equity trading strategies. This trading system is designed to identify high probability reversion to mean trading candidates. It looks to go long immediately following strong sell-offs, and goes short after sharp run ups. Its trades are short term and hone in on the irrational decisions of emotional traders around these extreme moves. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php The chart below displays the stocks expected to go Up and a suggested stop level to limit any potential trading losses.

     Symbol     Company                             Price          Price Stop Level
     EC         ECOPETROL SA-SPONSORED ADR          42.810         $41.33    
     NHI        NATL HEALTH INVESTORS INC           44.520         $42.83    
     ATO        ATMOS ENERGY CORP                   33.650         $31.95    
     TGI        TRIUMPH GROUP, INC.                 50.280         $48.34    
     BIIB       BIOGEN IDEC INC.                    99.270         $94.34    
     NST        NSTAR                               44.840         $43.04    

ECOPETROL SA-SPONSORED ADR (NYSE:EC) - Ecopetrol S.A. engages primarily in the exploration, production, refining, transportation, and commercialization of crude oil and gas in Columbia. It explores hydrocarbons in 32 blocks of Colombian territory directly, as well as in 15 blocks with other companies. The company engages in the crude oil and gas production activities, including the extraction, collection, treatment, storage, and pumping or compression of hydrocarbons. It also offers multimodal transportation services through its oil pipeline networks, multiple-use pipelines, and tankers. The company operates 53 stations pumping crude oil and products, as well as operates storage centers. In addition, Ecopetrol commercializes various crude oils and by-products, as well as operates Barrancabermeja and Cartagena refineries. It also operates in Brazil, Peru, and the United States. The company was formerly known as Empresa Colombiana De Petroleos and changed its name to Ecopetrol S.A. in June 2003. Ecopetrol S.A. was founded in 1948 and is based in Bogota, Colombia.

NATL HEALTH INVESTORS INC (NYSE:NHI) - National Health Investors, Inc., a real estate investment trust (REIT), invests in health care properties, primarily in the long-term care industry in the United States. As of December 31, 2008, it had investments in real estate assets and mortgage notes receivable investments in 123 health care facilities consisting of 83 long-term care facilities, 1 acute care hospital, 4 medical office buildings, 14 assisted living facilities, 4 retirement centers, and 17 residential projects for the developmentally disabled in 17 states. The company has elected to be treated as a REIT for federal income tax purposes and would not be subject to federal income tax, if it distributes at least 90% of its REIT taxable income to its shareholders. National Health Investors, Inc. was founded in 1991 and is based in Murfreesboro, Tennessee.

ATMOS ENERGY CORP (NYSE:ATO) - Atmos Energy Corporation, together with its subsidiaries, engages primarily in the distribution, transmission, and storage of natural gas in the United States. The company operates in four segments: Natural Gas Distribution; Regulated Transmission and Storage; Natural Gas Marketing; and Pipeline, Storage, and Other. The Natural Gas Distribution segment involves in regulated natural gas distribution business and related sales operations. It distributes natural gas through regulated sales and transportation arrangements to approximately 3 million residential, commercial, public authority, and industrial customers in 12 states located primarily in the southern United States. As of September 30, 2009, this segment owned approximately 70,879 miles of underground distribution and transmission mains. The Regulated Transmission and Storage segment transports natural gas for third parties and manages five underground storage reservoirs in Texas. It owned 5,950 miles of gas transmission and gathering lines. The Natural Gas Marketing segment provides various natural gas management and marketing services to municipalities, other local gas distribution companies, and industrial customers. The Pipeline, Storage, and Other segment offers natural gas gathering, transmission, and storage services. It owned 113 miles of gas transmission and gathering lines. Atmos Energy Corporation was founded in 1906 and is headquartered in Dallas, Texas.

TRIUMPH GROUP, INC. (NYSE:TGI) - Triumph Group, Inc., through its subsidiaries, engages in the design, engineering, manufacture, repair, overhaul, and distribution of aircraft components. The company operates in two segments, Aerospace Systems and Aftermarket Services. The Aerospace Systems segment provides mechanical and electromechanical controls, such as hydraulic systems and components, main engine gearbox assemblies, and accumulators and mechanical control cables. It also involves in stretch forming, die forming, milling, bonding, machining, welding, and assembling and fabricating various structural components used in aircraft wings, fuselages, and other assemblies. In addition, this segment provides composite assemblies for floor panels, environmental control system ducts, non-structural cockpit components, and thermal acoustic insulation systems. The Aftermarket Services segment provides maintenance, repair, and overhaul services for commercial and military markets. This segment offers its services on auxiliary power units, and air frame and engine accessories, including constant-speed drives, cabin compressors, starters and generators, and pneumatic drive units; and on thrust reversers, nacelle components, and flight control surfaces, as well as supplies spare parts of cockpit instruments and gauges for a range of commercial airlines. The company serves the aerospace industry, including original equipment manufacturers of commercial, regional, business, and military aircraft and components, as well as commercial airlines, air cargo carriers, and military customers. Triumph Group, Inc. was founded in 1993 and is based in Wayne, Pennsylvania.

BIOGEN IDEC INC. (NASDAQ:BIIB) - Biogen Idec Inc., a biotechnology company, discovers, develops, manufactures, and markets therapeutics in the areas of neurology, immunology, hemophilia, and oncology in the United States and internationally. Its marketed products include AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, CD20-positive, and B-cell Non-Hodgkins Lymphoma (NHL); TYSABRI to treat relapsing MS; and FUMADERM for the treatment of severe plaque psoriasis in adult patients. The companys products under Phase III consist of FAMPYRA, an oral compound that is being developed as a treatment to enhance walking ability in people with MS; BG-12 for the treatment of MS; Daclizumab, a monoclonal antibody in relapsing MS; PEGylated interferon beta-1a designed to prolong the effects and reduce the dosing frequency of interferon beta-1a; Dexpramipexole, an orally administered small molecule for the treatment of amyotrophic lateral sclerosis; Recombinant Factors VIII and IX for the treatment of hemophilia; and GA101, a monoclonal antibody for the treatment of chronic lymphocytic leukemia and NHL. Its Phase I clinical trial products include Anti-LINGO, Baminercept, and Neublastin for neurology, as well as Anti-TWEAK and CD40LFab for immunology; and Phase II clinical trial products comprise Anti-TWEAK and Baminercept for immunology. In addition, the companys preclinical stage products consist of BIIB034 for the treatment of Parkinsons disease; and BART and Gamma Secretase Modulator for Alzheimers disease. It has collaboration agreements with Neurimmune SubOne AG; Genentech, Inc.; UCB, S.A.; Acorda Therapeutics, Inc.; Elan Pharma International, Ltd; Swedish Orphan Biovitrum AB; Abbott Biotherapeutics Corp; Vernalis plc; and Amunix, Inc. The company was formerly known as IDEC Pharmaceuticals Corporation and changed its name to Biogen Idec Inc. in November 2003. Biogen Idec Inc. was founded in 1985 and is based in Weston, Massachusetts.

NSTAR (NYSE:NST) - NSTAR, through its subsidiaries, engages in the distribution, transmission, and sale of energy in Massachusetts. The company supplies electricity at retail in the City of Boston and 80 surrounding cities and towns, such as Cambridge, New Bedford, Plymouth, and the geographic area comprising Cape Cod and Marthas Vineyard. It distributes natural gas in central and eastern Massachusetts, including the Hyde Park area of Boston, Cambridge, Dedham, Framingham, New Bedford, Plymouth, Somerville, and Worcester. The company also involves in the telecommunications business comprising installation, ownership, operation, and maintenance of a wholesale transport network for other telecommunications service providers in the metropolitan Boston area to deliver voice, video, data, and Internet services to customers, as well as in liquefied natural gas service business. As of December 31, 2009, it served approximately 1.4 million customers, including approximately 1.1 million electric distribution customers in 81 communities and approximately 300,000 natural gas distribution customers in 51 communities. The company was founded in 1886 and is based in Boston, Massachusetts.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net